FBRX

Forte Biosciences (FBRX)

About Forte Biosciences (FBRX)

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Details

Daily high

$19.01

Daily low

$17.76

Price at open

$17.94

52 Week High

$35.80

52 Week Low

$9.10

Market cap

365.5M

Dividend yield

0.00%

Volume

233,948

Avg. volume

251,029

P/E ratio

-3.50

Forte Biosciences News